UNIVERSAL CORP /VA/ UVV
Universal Corporation is a global business-to-business agriproducts company with over 100 years of experience supplying products and innovative solutions to meet our customers' evolving needs. With operations in over 30 countries on five continents, we are uniquely positioned to leverage our worldwide network to access a diverse, reliable supply of plant-based materials. This presence, combined with our supply chain expertise, integrated processing capabilities, and commitment to sustainability, enables us to deliver high-quality, customizable, and traceable value-added agriproducts essential to our customers' success.
We have two operating segments: Tobacco Operations and Ingredients Operations. Our Tobacco Operations segment involves procuring and processing flue-cured, burley, dark air-cured, and oriental leaf tobacco for manufacturers of consumer tobacco products and performing related services. We are the leading global leaf tobacco supplier. Through our Ingredients Operations segment, we procure raw materials globally and process the raw materials through a variety of value-added manufacturing processes to produce high-quality, innovative, specialty plant-based ingredients, including fruits, vegetables, botanical extracts, and flavorings for consumer-packaged goods manufacturers, retailers, and food and beverage companies. We do not sell any direct-to-consumer products. Rather, we support consumer product manufacturers by selling them transformed agriproducts and performing related services for them.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- All Other Countries
- United States
- Belgium
- Indonesia
- Poland
- China
- Philippines
- Germany
- Italy
- France
- Netherlands
- Other
| Region | FY2025 |
|---|---|
| All Other Countries | $809.2M |
| United States | $659.4M |
| Belgium | $559.6M |
| Indonesia | $193.5M |
| Poland | $170.9M |
| China | $169.3M |
| Philippines | $151.5M |
| Germany | $65.8M |
| Italy | $51.9M |
| France | $41.4M |
| Netherlands | $29.1M |
| Other | $22.8M |
As the company reported it, from the “Operating Segments (Schedule Of Sales And Long-Lived Assets By Country) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Revenue by segment
- Tobacco Operations
- Ingredients Operations
| Segment | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Tobacco Operations | $2.58B | $2.61B | $2.44B |
| Ingredients Operations | $348.1M | $338.6M | $309.8M |
As the company reported it, from the “Operating Segments (Operating Results For The Company's Reportable Segments) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.89B | $2.92B | $2.72B | $2.55B | $2.09B | $1.97B | $1.89B | $2.21B | $2.02B | $2.05B |
| Cost of revenue | $2.41B | $2.40B | $2.21B | $2.11B | $1.69B | $1.60B | $1.55B | $1.82B | $1.66B | $1.68B |
| Gross profit | $472.6M | $524.3M | $509.2M | $438.3M | $396.5M | $368.1M | $338.7M | $392.6M | $356.9M | $370.8M |
| SG&A | $300.7M | $305.3M | $310.6M | $277.2M | $240.7M | $219.8M | $222.9M | $225.1M | $201.1M | $211.9M |
| Operating income | $168.5M | $232.8M | $222.0M | $181.1M | $160.3M | $147.8M | $126.4M | $161.2M | $170.8M | $178.4M |
| Interest expense | $74.0M | $79.6M | $66.3M | $49.3M | $27.7M | $25.0M | $19.9M | $17.5M | $15.6M | $16.3M |
| Pre-tax income | $102.7M | $154.2M | $164.1M | $142.0M | $142.3M | $125.7M | $113.3M | $151.3M | $166.7M | $169.2M |
| Income tax | $46.7M | $40.9M | $31.1M | $11.7M | $38.7M | $29.4M | $35.3M | $41.2M | $50.5M | $56.7M |
| Net income | $32.6K | $95.0K | $119.6K | $124.1K | $86.6K | $87.4M | $71.7M | $104.1M | $105.7M | $106.3M |
| EPS, basic | 1.30 | 3.81 | 4.81 | 5.01 | 3.50 | 3.55 | 2.87 | 4.14 | 4.18 | 0.89 |
| EPS, diluted | 1.30 | 3.78 | 4.78 | 4.97 | 3.47 | 3.53 | 2.86 | 4.11 | 4.14 | 0.88 |
| Shares, diluted (wtd. avg.) | 25.2M | 25.1M | 25.0M | 24.9M | 24.9M | 24.8M | 25.1M | 25.3M | 25.5M | 23.8M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $62.2M | $260.1M | $55.6M | $64.7M | $87.6M | $203.2M | $107.4M | $297.6M | $234.1M | $284.0M |
| Receivables | $563.9M | $625.9M | $525.3M | $402.1M | $385.4M | $367.5M | $340.7M | $368.1M | $377.1M | $439.3M |
| Total current assets | $1.97B | $2.16B | $2.10B | $1.80B | $1.75B | $1.56B | $1.48B | $1.59B | $1.59B | $1.56B |
| Property, plant and equipment | $373.0M | $373.0M | $365.9M | $351.2M | $345.1M | $349.5M | $315.2M | $302.5M | $323.8M | $317.3M |
| Goodwill | $172.7M | $213.8M | $213.9M | $213.9M | $214.0M | $173.1M | $126.8M | $97.9M | $98.8M | $98.8M |
| Other intangibles | $48.6M | $57.8M | $68.9M | $80.1M | $92.6M | $72.3M | $17.9M | $87.0K | — | — |
| Total assets | $2.77B | $2.99B | $2.94B | $2.64B | $2.59B | $2.34B | $2.12B | $2.13B | $2.17B | $2.12B |
| Accounts payable | — | — | — | — | $272.0M | $139.5M | $140.2M | $145.5M | $163.8M | $153.5M |
| Short-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total current liabilities | $564.2M | $750.2M | $711.4M | $442.0M | $518.7M | $293.2M | $267.4M | $253.7M | $267.7M | $268.0M |
| Long-term debt | $616.7M | $617.9M | $617.4M | $616.8M | $518.5M | $518.2M | $368.8M | $368.5M | $369.1M | $368.7M |
| Total liabilities | $1.31B | $1.49B | $1.46B | $1.20B | $1.20B | $993.5M | $831.6M | $753.3M | $783.3M | $796.8M |
| Retained earnings | $1.14B | $1.19B | $1.17B | $1.14B | $1.09B | $1.09B | $1.08B | $1.11B | $1.08B | $1.03B |
| Total equity | $1.42B | $1.46B | $1.48B | $1.44B | $1.38B | $1.35B | $1.29B | $1.38B | $1.39B | $1.33B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $129.1M | $327.0M | -$74.6M | -$10.6M | $44.9M | $220.4M | $10.9M | $164.5M | $81.2M | $250.3M |
| Depreciation and amortisation | $53.4M | $59.8M | $58.3M | $57.3M | $52.5M | $44.7M | $38.4M | $37.1M | $34.9M | $36.0M |
| Stock-based compensation | $7.1M | $8.5M | $12.1M | $8.4M | $6.2M | $6.1M | $5.6M | $8.2M | $7.6M | $6.5M |
| Capital expenditure | $48.8M | $62.6M | $66.0M | $54.7M | $53.2M | $66.2M | $35.2M | $38.8M | $34.0M | $35.6M |
| Investing cash flow | -$43.0M | -$58.8M | -$60.0M | -$50.4M | -$142.7M | -$217.3M | -$106.4M | -$34.7M | -$27.4M | -$33.9M |
| Financing cash flow | -$284.3M | -$63.2M | $125.7M | $38.9M | -$16.8M | $91.4M | -$94.1M | -$65.8M | -$104.6M | -$251.2M |
| Dividends paid | $81.3M | $79.7M | $78.4M | $77.4M | $76.4M | $75.2M | $75.4M | $69.9M | $54.7M | $49.8M |
| Buybacks | $0 | $0 | $4.7M | $3.4M | $3.1M | $0 | $33.5M | $1.4M | $21.6M | $0 |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001628280-26-046310.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.05B | $2.02B | $2.21B | $1.89B | $1.97B | $2.09B | $2.55B | $2.72B | $2.92B | $2.89B |
| Gross profit | $370.8M | $356.9M | $392.6M | $338.7M | $368.1M | $396.5M | $438.3M | $509.2M | $524.3M | $472.6M |
| Net income | $106.3M | $105.7M | $104.1M | $71.7M | $87.4M | $86.6K | $124.1K | $119.6K | $95.0K | $32.6K |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Officer or director change Item 5.02
- Results announced Item 2.02
- Officer or director change Item 5.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Officer or director change Item 5.02
- Officer or director change Item 5.02
- Regulation FD disclosure Item 7.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 5150
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| SEB | SEABOARD CORP /DE/ | $3.72B | 7.6x | 7.1% |
| ANDE | Andersons, Inc. | $2.21B | — | 9.1% |
| CHSCP | CHS INC | — | — | -9.7% |